We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNYSE:PFE
Raised
Post IPO Valuation

General Information

Websitepfizer.com
Twitter@pfizer_news
CategoryBioTech
Phone212-573-2323
Employees
Founded1848

Offices

New York, USA
235 East 42nd Street
New York, NY, 10017
USA

People

Chairman of the Board & CEO
President, Worldwide Research & Development
President & GM - Specialty Care & Oncology
President & GM - Primary Care Business Unit
VP, Corporate Audit
Board of Directors
Board of Directors
Board of Directors
Show All People

Acquisitions

Total$71.9B
NextWave Pharmaceuticals, 10/2012
ICAgen, 10/2011 $56M
King Pharmaceuticals, 10/2010 $3.6B
Foldrx Pharmaceuticals, 9/2010
Wyeth Pharmaceuticals, 1/2009 $68B
Encysive Pharmaceuticals, 2/2008 $195M

Investments

Aureon Laboratories 4/2010
Merus 1/2010

Tags

Pfizer

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizer’s diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer health care products. The Company operates in two business segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, and Consumer Healthcare products. On October 15, 2009, the Company completed its acquisition of Wyeth. In December 2009, Durata Therapeutics, Inc. acquired Vicuron Pharmaceuticals from Pfizer.

Pfizer, Inc. is an American multinational pharmaceutical corporation headquartered in New York City, and with its research headquarters in Groton, Connecticut, United States. It is one of the world’s largest pharmaceutical companies by revenues.

Pfizer develops and produces medicines and vaccines for a wide range of conditions including in the areas of immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain. Pfizer’s products include Lipitor (atorvastatin, used to lower LDL blood cholesterol); Lyrica (pregabalin, for neuropathic pain/fibromyalgia); Diflucan (fluconazole, an oral antifungal medication); Zithromax (azithromycin, an antibiotic); Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib, an anti-inflammatory drug).

Pfizer was founded by cousins Charles Pfizer and Charles Erhart in New York City in 1849 as a manufacturer of fine chemicals. Pfizer’s discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including of Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009, the latter acquired for US$68 billion. Pfizer is listed on the New York Stock Exchange and its shares have been a component of the Dow Jones Industrial Average since April 8, 2004.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Pfizer buying private NextWave for up to $680 mln (articles.marketwatch.com) [edit]
  2. Pfizer Acquires Icagen, Ends Fight By Two Venture Investors (fis.dowjones.com) [edit]
  3. Pfizer takes King in $3.6B pain gambit (fiercebiotech.com) [edit]
  4. Pfizer To Acquire FoldRx Pharmaceuticals (foldrx.com) [edit]
  5. en.wikipedia.org [edit]
  6. Pfizer to buy Encysive for $195 million (marketwatch.com) [edit]
  7. onbiovc.com [edit]
  8. Merus closes EUR 21.7 million Series B financing and enters option agreement with the Novartis Option Fund (merus.nl) [edit]
  9. Pfizer ends brain cancer vaccine deal with Celldex (masshightech.com) [edit]
    New Pfizer academic-industrial program based in Cambridge (masshightech.com) [edit]
    Pfizer ups ante on Santaris RNA discovery deal with $614M pact (fiercebiotech.com) [edit]
    UPDATED: Pfizer nabs autoimmune disease drug rights for $25M upfront (fiercebiotech.com) [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

Techmeme Posts Techmeme Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy